Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2019/05/019378
CTRI/2019/05/019378
Completed
Phase 3

Clinical experience with intravenous iron in anaemic patient receiving cancer treatment for epithelial ovarian carcinomas

Amrita University0 sites69 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsHealth Condition 1: C569- Malignant neoplasm of unspecifiedovary

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Health Condition 1: C569- Malignant neoplasm of unspecifiedovary
Sponsor
Amrita University
Enrollment
69
Status
Completed
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
September 1, 2021
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
Amrita University

Eligibility Criteria

Inclusion Criteria

  • •age 18–75 years with normal liver and kidney function, no prior radiotherapy
  • •and an Eastern Cooperative Oncology Group (ECOG) performance status
  • •\-Patient with epithelial ovarian cancer receiving Neoadjuvant or adjuvant chemotherapy or planned for surgery , having Hemoglobin level \=10 gm/dL

Exclusion Criteria

  • •Erythropoitin Stimulating Agent administration during chemotherapy course
  • •\-Allergic reaction to ferric carboxymaltose
  • •\- Serum ferritin \>800 ng/mL OR serum trasferrin saturation \>50%

Outcomes

Primary Outcomes

Not specified

Similar Trials

Active, not recruiting
Phase 1
Treatment of anemia (low red blood cells) with iron infusions in patients listed for a liver transplantatio
EUCTR2017-000703-24-ATMedical University of Vienna; Department of Surgery; Division of Transplantation60
Completed
Phase 3
Randomized controlled trial of the Effect of intraVenous iron on Anaemia in Malawian Pregnant women in their third trimester: REVAMP-TTAnaemiaIron-deficiencyHypophosphataemiaFoetal anaemiaInfectionChild developmentMaternal depressionBlood - AnaemiaMental Health - DepressionReproductive Health and Childbirth - Other reproductive health and childbirth disordersInfection - Other infectious diseases
ACTRN12621001239853Training and Research Unit of Excellence (TRUE), Malawi590
Not yet recruiting
Phase 2
IV iron infusion therapy in patients with persistent pai
ACTRN12622000412730Metro North Health Services Royal Brisbane and Women's Hospital160
Not yet recruiting
Not Applicable
Intravenous single dose iron infusioHealth Condition 1: D509- Iron deficiency anemia, unspecified
CTRI/2021/05/033579DST Chandigarh
Active, not recruiting
Phase 1
Effects of intravenous administered iron in non-anemic iron deficient patients with colorectal cancer.Iron-deficiency in colorectal cancerMedDRA version: 20.0Level: PTClassification code 10009944Term: Colon cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 20.0Level: PTClassification code 10038038Term: Rectal cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 20.0Level: PTClassification code 10022970Term: Iron deficiencySystem Organ Class: 10027433 - Metabolism and nutrition disordersTherapeutic area: Diseases [C] - Cancer [C04]
EUCTR2019-003819-56-DKCentre for Surgical Science134